| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
iRadimed (NASDAQ:IRMD) is looking for Q4 GAAP EPS of $0.43-$0.47 vs $0.41 analyst estimate..
iRadimed (NASDAQ:IRMD) is looking for Q4 Adj EPS of $0.47-$0.51 vs $0.47 analyst estimate. sees sales of $21.400 million-$22.40...
iRadimed (NASDAQ:IRMD) raises FY2025 GAAP EPS guidance from $1.60-$1.70 to $1.68-$1.72 vs $1.65 analyst estimate..
iRadimed (NASDAQ:IRMD) raises FY2025 Adj EPS guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 analyst estimate. Raises FY2025 ...
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.46 by 3.3...